BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37608146)

  • 1. Assessing the impact of the 2018 Changchun Changsheng vaccine incident on childhood vaccination in China.
    Hou Z; Lai X; Liu Y; Jit M; Larson HJ; Fang H
    Commun Med (Lond); 2023 Aug; 3(1):114. PubMed ID: 37608146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The determinants of vaccine hesitancy in China: A cross-sectional study following the Changchun Changsheng vaccine incident.
    Du F; Chantler T; Francis MR; Sun FY; Zhang X; Han K; Rodewald L; Yu H; Tu S; Larson H; Hou Z
    Vaccine; 2020 Nov; 38(47):7464-7471. PubMed ID: 33041097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coverage and Equity of Childhood Vaccines in China.
    Zhang H; Lai X; Mak J; Sriudomporn S; Zhang H; Fang H; Patenaude B
    JAMA Netw Open; 2022 Dec; 5(12):e2246005. PubMed ID: 36484985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caregiver and service provider vaccine confidence following the Changchun Changsheng vaccine incident in China: A cross-sectional mixed methods study.
    Tu S; Sun FY; Chantler T; Zhang X; Jit M; Han K; Rodewald L; Du F; Yu H; Hou Z; Larson H
    Vaccine; 2020 Oct; 38(44):6882-6888. PubMed ID: 32912643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with recommendation behaviors of four non-National Immunization Program vaccines: a cross-sectional survey among public health workers in China.
    Lyu Y; Lai X; Ma Y; Fang H
    Infect Dis Poverty; 2023 Oct; 12(1):91. PubMed ID: 37805654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization coverage, knowledge, satisfaction, and associated factors of non-National Immunization Program vaccines among migrant and left-behind families in China: evidence from Zhejiang and Henan provinces.
    Zhou Y; Li D; Cao Y; Lai F; Wang Y; Long Q; Zhang Z; An C; Xu X
    Infect Dis Poverty; 2023 Oct; 12(1):93. PubMed ID: 37833775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine confidence in China after the Changsheng vaccine incident: a cross-sectional study.
    Liu B; Chen R; Zhao M; Zhang X; Wang J; Gao L; Xu J; Wu Q; Ning N
    BMC Public Health; 2019 Nov; 19(1):1564. PubMed ID: 31771543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine bidding, procurement and distribution management practices in mainland China: A nationwide study.
    Wang W; Wang Y; Wang Y; Yan F; Wang N; Fu C
    Vaccine; 2021 Dec; 39(52):7584-7589. PubMed ID: 34802784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of non-National Immunization Program vaccination intentions in rural areas of China.
    Wang X; Fan Y; Wang W
    BMC Public Health; 2023 Aug; 23(1):1485. PubMed ID: 37542236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chinese social media suggest decreased vaccine acceptance in China: An observational study on Weibo following the 2018 Changchun Changsheng vaccine incident.
    Hu D; Martin C; Dredze M; Broniatowski DA
    Vaccine; 2020 Mar; 38(13):2764-2770. PubMed ID: 32093982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixing of diphtheria, tetanus, and acellular pertussis (DTaP) vaccines in a population of children in managed care.
    Masseria C; Buikema AR; Liu F; Krishnarajah G
    Hum Vaccin Immunother; 2015; 11(5):1175-83. PubMed ID: 25714800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The new National Immunization Program 2017-2019 and the Essential Care Levels: what is going to change?].
    De Waure C; Sisti LG; Poscia A; Ricciardi W
    Ig Sanita Pubbl; 2017; 73(5):405-418. PubMed ID: 29433128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children.
    Pichichero ME; Edwards KM; Anderson EL; Rennels MB; Englund JA; Yerg DE; Blackwelder WC; Jansen DL; Meade BD
    Pediatrics; 2000 Jan; 105(1):e11. PubMed ID: 10617748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-appropriate versus up-to-date coverage of routine childhood vaccinations among young children in Israel.
    Stein-Zamir C; Israeli A
    Hum Vaccin Immunother; 2017 Sep; 13(9):2102-2110. PubMed ID: 28696824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring parents' acceptance of non-national immunization program vaccines for children and its influencing factors during the COVID-19 pandemic in Shanghai, China.
    Wu L; Huang Z; Guo X; Liu J; Sun X
    Hum Vaccin Immunother; 2022 Nov; 18(5):2069427. PubMed ID: 35727599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody persistence after a primary series of a new DTaP-IPV-Hep B-PRP-T combined vaccine or separate DTaP-IPV//PRP-T and hepatitis B vaccines at 2, 4, and 6 months of age and the effect of a subsequent DTaP-IPV//PRP-T booster vaccination at 18 months of age in healthy Argentinean infants.
    Tregnaghi M; Zambrano B; Santos-Lima E
    Pediatr Infect Dis J; 2012 Jan; 31(1):e24-30. PubMed ID: 22157567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. China's practical wisdom: Assumption of liability for endangering public health in bankruptcy proceedings-A case study of the Changchun Changsheng Biotechnology vaccine incident and the Johnson & Johnson baby powder incident.
    Huang C
    Front Public Health; 2022; 10():1003330. PubMed ID: 36438243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How are children who are delayed in the Childhood Vaccination Programme vaccinated: A nationwide register-based cohort study of Danish children aged 15-24 months and semi-structured interviews with vaccination providers.
    Pedersen KB; Holck ME; Jensen AKG; Suppli CH; Benn CS; Krause TG; Sørup S
    Scand J Public Health; 2020 Feb; 48(1):96-105. PubMed ID: 30024308
    [No Abstract]   [Full Text] [Related]  

  • 20. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
    Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
    Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.